593
Participants
Start Date
April 30, 2008
Primary Completion Date
June 30, 2009
Study Completion Date
August 31, 2009
varenicline tartrate (CP-526, 555-18)
1 mg twice a day for 12 weeks, starting with a 1-week titration period.
Placebo
matching placebo 1 tablet twice a day for 12 weeks
Pfizer Investigational Site, Medellín
Pfizer Investigational Site, Barranquilla
Pfizer Investigational Site, Dubai
Pfizer Investigational Site, Al Ain City
Pfizer Investigational Site, Dubai
Pfizer Investigational Site, Jumeirah/Dubai
Pfizer Investigational Site, Ras Al Khaima
Pfizer Investigational Site, Caracas
Pfizer Investigational Site, Gran Caracas
Pfizer Investigational Site, Benoni
Pfizer Investigational Site, Midrand
Pfizer Investigational Site, Barquisimeto
Pfizer Investigational Site, Durban
Pfizer Investigational Site, Sydenham, Durban
Pfizer Investigational Site, Durban
Pfizer Investigational Site, Tygerberg
Pfizer Investigational Site, Paarl, Cape Town
Pfizer Investigational Site, Cape Town
Pfizer Investigational Site, Bloemfontein
Pfizer Investigational Site, Riyadh
Pfizer Investigational Site, México
Pfizer Investigational Site, Jeddah
Pfizer Investigational Site, Morelia
Pfizer Investigational Site, Monterrey
Pfizer Investigational Site, Fortaleza
Pfizer Investigational Site, Porto Alegre
Pfizer Investigational Site, Juiz de Fora
Pfizer Investigational Site, Botucatu
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, São Paulo
Pfizer Investigational Site, San Pedro
Pfizer Investigational Site, Cairo
Pfizer Investigational Site, Amman
Pfizer Investigational Site, Beirut
Pfizer Investigational Site, Pretoria
Pfizer Investigational Site, Soweto
Pfizer Investigational Site, Abu Dhabi
Pfizer Investigational Site, Caracas
Pfizer Investigational Site, Beirut Lebanon
Pfizer Investigational Site, Hillcrest
Pfizer Investigational Site, Lyttelton
Lead Sponsor
Pfizer
INDUSTRY